Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1

Biochemical and Biophysical Research Communications

Volumn 347, Issue 3, 2006, Pages 774-780

  Jagadeesh, Shankar ^a   Banerjee, Partha P ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

BPH 1; Cell cycle; Cyclin D1; DU 145; hTERT; Prostate cancer; Telomerase

Indexed keywords

CYCLIN D1; SHORT HAIRPIN RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CANCER CELL; CELL CYCLE REGULATION; CHROMOSOME SIZE; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; MODULATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; REGULATORY MECHANISM; TELOMERE; TRANSCRIPTION INITIATION; UPREGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL CYCLE; CELL LINE, TUMOR; CYCLIN D1; DNA-BINDING PROTEINS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MALE; PROSTATE; TELOMERASE; TRANSCRIPTION, GENETIC;

EID: 33746190649     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.06.172     Document Type: Article

References (31)

1. Greider C.W., and Blackburn E.H. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337 (1989) 331-337
2. Kim N.W., Piatyszek M.A., Prowse K.R., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266 (1994) 2011-2015
3. Harley C.B., and Villeponteau B. Telomeres and telomerase in aging and cancer. Curr. Opin. Genet. Dev. 5 (1995) 249-255
4. Kilian A., Bowtell D.D., Abud H.E., et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum. Mol. Genet. 6 (1997) 2011-2019
5. Feng J., Funk W.D., Wang S.S., Weinrich S.L., Avilion A.A., Chiu C.P., Adams R.R., Chang E., Allsopp R.C., Yu J., et al. The RNA component of human telomerase. Science 269 (1995) 1236-1241
6. Harrington L., McPhail T., Mar V., Zhou W., Oulton R., Bass M.B., Arruda I., and Robinson M.O. A mammalian telomerase-associated protein. Science 275 (1997) 973-977
7. Holt S.E., Aisner D.L., Baur J., Tesmer V.M., Dy M., Ouellette M., Trager J.B., Morin G.B., Toft D.O., Shay J.W., Wright W.E., and White M.A. Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev. 13 (1999) 817-826
8. Nakano K., Watney E., and McDougall J.K. Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cance. Am. J. Pathol. 153 (1998) 857-864
9. Boldrini L., Faviana P., Gisfredi S., et al. Evaluation of telomerase in the development and progression of colon cancer. Int. J. Mol. Med. 10 (2002) 589-592
10. Park T.W., Riethdorf S., Riethdorf L., Loning T., and Janicke F. Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors. Int. J. Cancer 84 (1999) 426-431
11. Kanaya T., Kyo S., Takakura M., Ito H., Namiki M., and Inoue M. hTERT is a critical determinant of telomerase activity in renal-cell carcinoma. Int. J. Cancer 78 (1998) 539-543
12. Blasco M.A., and Hahn W.C. Evolving views of telomerase and cancer. Trends Cell Biol. 13 (2003) 289-294
13. Stewart S.A., Hahn W.C., O'Connor B.F., Banner E.N., Lundberg A.S., Modha P., Mizuno H., Brooks M.W., Fleming M., Zimonjic D.B., Popescu N.C., and Weinberg R.A. Telomerase contributes to tumorigenesis by a telomere length independent mechanism. Proc. Natl. Acad. Sci. USA 99 (2002) 12606-12611
14. Smith L.L., Coller H.A., and Roberts J.M. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat. Cell Biol. 5 (2003) 474-479
15. Canela A., Martin-Caballero J., Flores J.M., and Blasco M.A. Constitutive expression of tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-Tert mice. Mol. Cell Biol. 24 (2004) 4275-4293
16. Chung H.K., Cheong C., Song J., and Lee H.W. Extratelomeric functions of telomerase. Curr. Mol. Med. 5 (2005) 233-241
17. Sung Y.H., Choi Y.S., Cheong C., and Lee H.W. The pleiotropy of telomerase against cell death. Mol. Cells 19 (2005) 303-309
18. Fu M., Wang C., Li Z., Sakamaki T., and Pestell R.G. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 145 (2004) 5439-5447
19. Albanese C., Johnson J., Watanabe G., Eklund N., Vu D., Arnold A., and Pestell R.G. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270 (1995) 23589-23597
20. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., and Ben-Ze'ev A. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA 96 (1999) 5522-5527
21. Albanese C., Wu K., D'Amico M., Jarrett C., Joyce D., Hughes J., Hulit J., Sakamaki T., Fu M., Ben-Ze'ev A., Bromberg J.F., Lamberti C., Verma U., Gaynor R.B., Byers S.W., and Pestell R.G. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Mol. Biol. Cell 14 (2003) 585-599
22. Bakiri L., Lallemand D., Bossy-Wetzel E., and Yaniv M. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J. 19 (2000) 2056-2068
23. Diehl J.A., Cheng M., Roussel M.F., and Sherr C.J. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12 (1998) 3499-3511
24. Koike H., Suzuki K., Satoh T., Ohtake N., Takei T., Nakata S., and Yamanaka H. Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage. Anticancer Res. 23 (2003) 4947-4951
25. Drobnjak M., Osman I., Scher H.I., Fazzari M., and Cordon-Cardo C. Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clin. Cancer Res. 6 (2000) 891-1895
26. Chen Y., Martinez L.A., LaCava M., Coghlan L., and Conti C.J. Increased cell growth and tumorigenicity in human prostate LNCaP cells by overexpression to cyclin D1. Oncogene 16 (1998) 1913-1920
27. Wang T.C., Cardiff R.D., Zukerberg L., Lees E., Arnold A., and Schmidt E.V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369 (1994) 669-671
28. Nelsen C.J., Rickheim D.G., Timchenko N.A., Stanley M.W., and Albrecht J.H. Transient expression of cyclin D1 is sufficient to promote hepatocyte replication and liver growth in vivo. Cancer Res. 61 (2001) 8564-8568
29. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., Horii I., Loh D.Y., and Nakayama K. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85 (1996) 707-720
30. Arato-Ohshima T., and Sawa H. Over-expression of cyclin D1 induces glioma invasion by increasing matrix metalloproteinase activity and cell motility. Int. J. Cancer 83 (1999) 387-392
31. Drobnjak M., Osman I., Scher H.I., Fazzari M., and Cordon-Cardo C. Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clin. Cancer Res. 6 (2000) 1891-1895